Published in Trans R Soc Trop Med Hyg on January 26, 2001
Taenia solium cysticercosis. Lancet (2003) 5.89
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
Neglected and endemic zoonoses. Philos Trans R Soc Lond B Biol Sci (2009) 1.79
Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry (2007) 1.77
Immunological and molecular diagnosis of cysticercosis. Pathog Glob Health (2012) 1.20
Diagnosis and treatment of neurocysticercosis. Interdiscip Perspect Infect Dis (2009) 1.15
Neurocysticercosis in children presenting with afebrile seizure: clinical profile, imaging and serodiagnosis. Rev Inst Med Trop Sao Paulo (2014) 1.05
Epilepsy and neurocysticercosis: an incidence study in a Peruvian rural population. Neuroepidemiology (2009) 1.04
Diagnosis of parasitic diseases: old and new approaches. Interdiscip Perspect Infect Dis (2009) 1.03
Monitoring the outcomes of interventions against Taenia solium: options and suggestions. Parasite Immunol (2016) 0.94
Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr (2009) 0.93
Neurocysticercosis: HP10 antigen detection is useful for the follow-up of the severe patients. PLoS Negl Trop Dis (2013) 0.89
Extraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive Review. J Clin Neurol (2015) 0.85
Parasite antigen in serum predicts the presence of viable brain parasites in patients with apparently calcified cysticercosis only. Clin Infect Dis (2013) 0.84
Anti-Taenia solium larval stage Ig G antibodies in patients with epileptic seizures. Trop Parasitol (2011) 0.82
Parasitic diseases of the central nervous system: lessons for clinicians and policy makers. Expert Rev Neurother (2016) 0.81
Immunodiagnosis of neurocysticercosis: ways to focus on the challenge. J Biomed Biotechnol (2011) 0.78
A rapid slide agglutination test for the diagnosis of neurocysticercosis in the rural health set up. Trop Parasitol (2011) 0.78
Tropical diseases of the myocardium: a review. Int J Gen Med (2017) 0.75
Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Parasitol Res (2016) 0.75
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol (1998) 7.84
Enzyme-linked immunoelectrotransfer blot techniques (EITB) for studying the specificities of antigens and antibodies separated by gel electrophoresis. Methods Enzymol (1983) 6.86
Identification of 5 types of Cryptosporidium parasites in children in Lima, Peru. J Infect Dis (2000) 6.71
Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis. Science (1999) 6.07
Taenia solium cysticercosis. Lancet (2003) 5.89
India ink staining of proteins on nitrocellulose paper. Anal Biochem (1983) 5.78
A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. N Engl J Med (2004) 5.75
Neurocysticercosis: updated concepts about an old disease. Lancet Neurol (2005) 5.37
Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol (2000) 5.01
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet (1975) 4.85
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial. Lancet Infect Dis (2014) 4.64
Cyclospora species--a new protozoan pathogen of humans. N Engl J Med (1993) 4.56
Community infection ratio as an indicator for tuberculosis control. Lancet (1995) 3.53
Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol (2000) 3.39
Effect of El Niño and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children. Lancet (2000) 3.11
Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg (1978) 3.06
Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol (2008) 3.04
Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med (1978) 2.95
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science (1993) 2.85
Cysticercosis as a major cause of epilepsy in Peru. The Cysticercosis Working Group in Peru (CWG) Lancet (1993) 2.66
Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology (1997) 2.60
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine. J Infect Dis (1977) 2.57
Calcific neurocysticercosis and epileptogenesis. Neurology (2004) 2.57
Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. J Neurol Sci (1996) 2.57
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Candidate for immunoglobulin D present on murine B lymphocytes. Nature (1974) 2.29
Molecular assays for surveillance of antifolate-resistant malaria. Lancet (1998) 2.26
Immunoglobulin M biosynthesis. Intracellular accumulation of 7S subunits. Biochem J (1969) 2.24
Effects of Cryptosporidium parvum infection in Peruvian children: growth faltering and subsequent catch-up growth. Am J Epidemiol (1998) 2.17
Elimination of Taenia solium Transmission in Northern Peru. N Engl J Med (2016) 2.15
Detection of Taenia solium antigens and anti-T. solium antibodies in paired serum and cerebrospinal fluid samples from patients with intraparenchymal or extraparenchymal neurocysticercosis. J Infect Dis (2009) 2.06
A placebo-controlled trial of Lactobacillus GG to prevent diarrhea in undernourished Peruvian children. J Pediatr (1999) 2.05
Neurocysticercosis: association between seizures, serology, and brain CT in rural Peru. Neurology (2005) 2.04
Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99
Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. J Infect Dis (1991) 1.95
Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95
Fecal contamination of shanty town toddlers in households with non-corralled poultry, Lima, Peru. Am J Public Health (1990) 1.89
Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. Am J Trop Med Hyg (1990) 1.88
Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84
Asymptomatic and symptomatic cryptosporidiosis: their acute effect on weight gain in Peruvian children. Am J Epidemiol (1997) 1.82
Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol (2000) 1.77
The role of non-biting flies in the epidemiology of human infectious diseases. Microbes Infect (2001) 1.74
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Quantitative, single-tube, kinetic-dependent enzyme-linked immunosorbent assay (k-ELISA). Methods Enzymol (1983) 1.72
Differential diagnosis between cerebral tuberculosis and neurocysticercosis by magnetic resonance spectroscopy. J Comput Assist Tomogr (2005) 1.67
Hyperendemic pulmonary tuberculosis in a Peruvian shantytown. Am J Epidemiol (1998) 1.67
A new coccidian parasite (Apicomplexa: Eimeriidae) from humans. J Parasitol (1994) 1.65
Magnitude of the disease burden from neurocysticercosis in a developing country. Clin Infect Dis (1999) 1.63
Demonstration of species-specific and cross-reactive components of the adult microsomal antigens from Schistosoma mansoni and S. japonicum (MAMA and JAMA). J Immunol (1984) 1.63
Diagnosis of cysticercosis in endemic regions. The Cysticercosis Working Group in Peru. Lancet (1991) 1.63
Prevalence and prediction of hypoxemia in children with respiratory infections in the Peruvian Andes. J Pediatr (1991) 1.62
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62
The degree of neutropenia has a prognostic impact in low risk myelodysplastic syndrome. Leuk Res (2011) 1.58
Helicobacter pylori populations in Peruvian patients. Clin Infect Dis (1997) 1.57
Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures. PLoS Negl Trop Dis (2009) 1.55
Prevalence of antibody to the Norwalk virus in various countries. Infect Immun (1979) 1.54
Swine cysticercosis hotspots surrounding Taenia solium tapeworm carriers. Am J Trop Med Hyg (2007) 1.54
Assembly of immunoglobulin M. Blocked thiol groups of intracellular 7S subunits. Biochem J (1971) 1.53
Immunodiagnosis of human cysticercosis (Taenia solium): a field comparison of an antibody-enzyme-linked immunosorbent assay (ELISA), an antigen-ELISA, and an enzyme-linked immunoelectrotransfer blot (EITB) assay in Peru. The Cysticercosis Working Group in Peru (CWG). Am J Trop Med Hyg (1992) 1.53
Isolation of Cryptosporidium parvum and Cyclospora cayetanensis from vegetables collected in markets of an endemic region in Peru. Am J Trop Med Hyg (1997) 1.53
Short report: transient antibody response in Taenia solium infection in field conditions-a major contributor to high seroprevalence. Am J Trop Med Hyg (2001) 1.52
Immunoglobulin M biosynthesis. Production of intermediates and excess of light-chain in mouse myeloma MOPC 104E. Biochem J (1971) 1.51
Gallstone disease in high-altitude Peruvian rural populations. Am J Gastroenterol (1999) 1.51
Changing proteins on the surface of a parasitic nematode. Nature (1980) 1.50
Pulmonary tuberculosis in children in a developing country. Pediatrics (2001) 1.50
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48
Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44
Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody. J Immunol Methods (1982) 1.43
Epidemiology and treatment of Cyclospora cayetanensis infection in Peruvian children. Clin Infect Dis (1997) 1.43
Tuberculosis in household contacts of multidrug-resistant tuberculosis patients. Int J Tuberc Lung Dis (2011) 1.43
Schistosomiasis in Lake Malawi. Lancet (1996) 1.42
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Immunoblot (western blot) and double diffusion (DD5) tests for hydatid disease cross-react with sera from patients with cysticercosis. Trans R Soc Trop Med Hyg (1992) 1.41
Comparison of three methods to obtain upper small bowel contents for culture. Am J Gastroenterol (1993) 1.41
Cholera incidence and El Niño-related higher ambient temperature. JAMA (2000) 1.40